[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-244202-105":53,"doc-detail-244202-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","research-prioritisation-framework-january-2020","Research Prioritisation Framework - January 2020","","A practical guide for Clinical Trial Networks (CTNs) and other health research organisations to set priorities for clinical trials under limited resources. It outlines a continuous, adaptable good-practice framework covering leadership and governance, scoping and objectives, stakeholder engagement, development of selection criteria, methods to weight and score criteria, topic identification, proposal generation, selection of proposals, and concluding evaluation. Includes acknowledgements, disclaimer, abbreviations, references, and tool-method appendices.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/research-prioritisation-framework-january-2020/244202/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/research-prioritisation-framework-january-2020/244202.png","ImageObject",442,249,{"name":88,"@type":89},"Adam","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-09-20","2026-09-12",true,{"@type":98,"interactionType":99,"userInteractionCount":73},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"Who is this Research Prioritisation Framework intended for?","Question",{"text":108,"@type":109},"It assists Clinical Trial Networks (CTNs) and other organisations interested in setting priorities for the conduct of clinical trials, including funding organisations and government stakeholders.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What problem does the framework address?",{"text":113,"@type":109},"It addresses the need to direct limited resources—funding, staff time, infrastructure, and participant recruitment capacity—toward trials that answer important stakeholder questions and represent strong investment.",{"name":115,"@type":106,"acceptedAnswer":116},"What main steps does the framework cover?",{"text":117,"@type":109},"It covers forming a leadership team, defining scope and objectives, identifying and engaging stakeholders, developing selection criteria, weighting and scoring criteria, identifying topics, generating proposals, selecting proposals, and concluding with evaluation.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},244202,1789213707,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":73,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":125,"read_time":140},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Research Prioritisation Framework  \nJanuary 2020  \nACTA gratefully acknowledges operational funding from the Australian Government’s Medical Research Future Fund  \nTABLE OF CONTENTS  \nThe purpose of this document 3  \nAcknowledgements 3  \nUse of this document 3  \nDisclaimer 3  \nAbbreviations 3  \nIntroduction 4  \nA good practice framework 4  \n1. Form a leadership team 6  \n2. Develop scope and objectives 6  \n3. Identify and engage stakeholders 7  \n4. Develop selection criteria 7  \n5. Methods to weight and score criteria 9  \n6. Identify topics 10  \n7. Select topics 11  \n8. Generate research proposals 11  \n9. Select research proposals 12  \n10. Conclude and evaluate 12  \nReferences 14  \nAppendix A: ACTA Reference Group on Tools for Research Prioritisation 15  \nAppendix B: Methods, approaches and criteria for health research prioritisation 16  \nResearch Prioritisation Framework Page 2 of 19  \nTHE PURPOSE OF THIS DOCUMENT  \nThis document will assist Clinical Trial Networks (CTNs) and other organisations who are interested in setting priorities for the conduct of clinical trials (e.g., Australian Government, funding organisations) .  \nACKNOWLEDGEMENTS  \nThis document was developed by A/Prof Haitham Tuffaha, with input from Prof Rachael Morton, Anitha Balagurunathan, Miranda Cumpston, and ACTA’s Reference Group on Tools for Research Prioritisation (see Appendix A) . The guidance included draws on a range of resources, including the framework developed by Nasser and colleagues (Nasser 2013), as well as a review of prioritisation methodologies by Tuffaha and colleagues (Tuffaha etal 2018), a survey of Australian Clinical Trials Networks and Coordinating Centres, and a pragmatic review of current practice in prioritisation for clinical trials.  \nWe acknowledge the contributions of ACTA CTN members and members of ACTA’s Tools for Research Prioritisation Reference Group in the preparation, development and review of this document.  \nUSE OF THIS DOCUMENT  \nACTA requests that the following acknowledgement is included in any CTN operational processes that are developed and documented using knowledge gained from this document. This will assist ACTA in identifying the usefulness and impact of this document in creating efficient and effective processes for CTNs.  \n“[Name ofCTN] acknowledges the contribution of ACTA to the development of operational processes within our network (reference: Research Prioritisation Framework).”  \nDISCLAIMER  \nThe information in this document is for general guidance only. ACTA does not make any representations or warranties (expressed or implied) as to the accuracy, currency or authenticity of the information provided.  \nABBREVIATIONS  \n\n| ACTA | Australian Clinical Trials Alliance |\n| --- | --- |\n| CTN | Clinical Trials Network |\n| WHO | World Health Organisation |\n| AKTN | Australasian Kidney Trials Network |\n| ANZMUSC | Australia & New Zealand Musculoskeletal Clinical Trials Network |\n| COHRED | Council on Health Research for Development |\n| MCDA | Multiple criteria decision analysis |\n\nResearch Prioritisation Framework Page 3 of 19  \nINTRODUCTION  \nClinical trials are conducted in an environment of limited resources – whether that be the allocation of funding, the dedication of staff time and infrastructure, or the capacity of the health system to recruit participants. With that in mind, it is important to ensure that resources and capacity are directed to trials that answer questions of importance to stakeholders, and that represent the best possible investment.  \nPrioritisation can be reflected in a number of different activities: consultation processes generate topics of interest or specific proposals for further research; funders rank and weight specific research proposals to allocate limited funding; and Clinical Trials Networks (CTNs) assess trial proposals to meet minimum standards for endorsement and support by the CTN community of trialists.  \nWhile some CTNs already undertake large-scale consultation and ","cbCairX6p1dNRQZd","https://ap.wps.com/l/cbCairX6p1dNRQZd","pdf",643634,19,"English","# The purpose of this document\n# Acknowledgements\n# Use of this document\n# Disclaimer\n# Abbreviations\n# Introduction\n## A good practice framework\n# Form a leadership team\n# Develop scope and objectives\n# Identify and engage stakeholders\n# Develop selection criteria\n# Methods to weight and score criteria\n# Identify topics\n# Select topics\n# Generate research proposals\n# Select research proposals\n# Conclude and evaluate\n# References\n# Appendix A: ACTA Reference Group on Tools for Research Prioritisation\n# Appendix B: Methods, approaches and criteria for health research prioritisation","[{\"question\":\"Who is this Research Prioritisation Framework intended for?\",\"answer\":\"It assists Clinical Trial Networks (CTNs) and other organisations interested in setting priorities for the conduct of clinical trials, including funding organisations and government stakeholders.\"},{\"question\":\"What problem does the framework address?\",\"answer\":\"It addresses the need to direct limited resources—funding, staff time, infrastructure, and participant recruitment capacity—toward trials that answer important stakeholder questions and represent strong investment.\"},{\"question\":\"What main steps does the framework cover?\",\"answer\":\"It covers forming a leadership team, defining scope and objectives, identifying and engaging stakeholders, developing selection criteria, weighting and scoring criteria, identifying topics, generating proposals, selecting proposals, and concluding with evaluation.\"}]","Research Prioritisation Framework - January 2020 | PDF",7]